Device
Magpro X100 + Option
Magpro X100 + Option is a medical device with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
withdrawn125%
terminated125%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Magnetic Seizure Therapy for Bipolar Mania
NCT03160664
completednot_applicable
Predict MDE Outcomes After MST
NCT03841019
withdrawnnot_applicable
Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Mania
NCT03016104
terminatednot_applicable
Magnetic Seizure Therapy for Schizophrenia
NCT02746965
Clinical Trials (4)
Showing 4 of 4 trials
NCT03160664Not Applicable
Magnetic Seizure Therapy for Bipolar Mania
NCT03841019Not Applicable
Predict MDE Outcomes After MST
NCT03016104Not Applicable
Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Mania
NCT02746965Not Applicable
Magnetic Seizure Therapy for Schizophrenia
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4